Skip to main content
Clinical Trials/JPRN-UMIN000029543
JPRN-UMIN000029543
Completed
未知

A Prospective Study, Multi-center Investigation of Impact of the Reinforced Staple Technology during Anastomosis of Laparoscopic Rectal Surgery - A Prospective Study, Multi-center Investigation of Impact of the Reinforced Staple Technology during Anastomosis of Laparoscopic Rectal Surgery

Sapporo Medical University0 sites307 target enrollmentOctober 15, 2017
ConditionsColon cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Colon cancer
Sponsor
Sapporo Medical University
Enrollment
307
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 15, 2017
End Date
September 30, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients with serious ischemic heart disease; 2\)Patients with cirrhosis or active hepatitis; 3\)Patients with dyspnea requiring oxygen administration; 4\)Patients under dialysis due to chronic renal failure; 5\)Patients requiring combined resection of any other organ; or 6\)Patients ineligible for the study for any other reason, as judged by the investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A Prospective Study, Multi-center Investigation of outocome of the Reinforced Staple Technology during Anastomosis of Laparoscopic Rectal SurgeryRectal cancer
JPRN-UMIN000037489Sapporo Medical University300
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-BEActelion Pharmaceuticals Ltd.200
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.Clostridium difficile-associated diarrhea (CDAD)MedDRA version: 20.0Level: LLTClassification code 10012734Term: Diarrhea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10054236Term: Clostridium difficile infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10022661Term: Intestinal infection due to clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10012748Term: Diarrhoea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2015-004805-17-ESActelion Pharmaceuticals Ltd.1
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-ITActelion Pharmaceuticals Ltd.200
Active, not recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-HUActelion Pharmaceuticals Ltd.200